I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
DataSheet1_Pharmacokinetics, absorption, distribution, meta..:
Yvonne Füll
;
Christian Wallasch
;
Ashley Hilton
.
doi:10.3389/fphar.2022.1050193.s001. , 2022
Link:
https://doi.org/10.3389/fphar.2022.1050193.s001
RT Journal T1
DataSheet1_Pharmacokinetics, absorption, distribution, metabolism and excretion of the MEK inhibitor zapnometinib in rats.pdf
UL https://suche.suub.uni-bremen.de/peid=base-ftfrontimediafig:oai:figshare.com:article_21672227&Exemplar=1&LAN=DE A1 Yvonne Füll A1 Christian Wallasch A1 Ashley Hilton A1 Oliver Planz YR 2022 K1 Pharmacology K1 Basic Pharmacology K1 Clinical Pharmacology and Therapeutics K1 Clinical Pharmacy and Pharmacy Practice K1 Pharmaceutical Sciences K1 Pharmacogenomics K1 Toxicology (incl. Clinical Toxicology) K1 Pharmacology and Pharmaceutical Sciences not elsewhere classified K1 mek inhibitor K1 absorption K1 distribution K1 metabolism K1 excretion K1 antiviral therapy K1 zapnometinib JF doi:10.3389/fphar.2022.1050193.s001 LK http://dx.doi.org/https://doi.org/10.3389/fphar.2022.1050193.s001 DO https://doi.org/10.3389/fphar.2022.1050193.s001 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)